Published in Clinical Oncology Week, November 6th, 2006
According to a study from Japan, "We performed this study to determine the role and prognostic factors of neoadjuvant therapy followed by surgery for locally advanced non-small cell cancer. One hundred patients with clinical stage III non-small cell lung cancer (79 IIIA, 21 11113; 78 males, 22 females; average age 60.5 years) received neoadjuvant therapy,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.